Cargando…
Trefoil Factor 3, Cholinesterase and Homocysteine: Potential Predictors for Parkinson’s Disease Dementia and Vascular Parkinsonism Dementia in Advanced Stage
Trefoil factor 3 (TFF3), cholinesterase activity (ChE activity) and homocysteine (Hcy) play critical roles in modulating recognition, learning and memory in neurodegenerative diseases, such as Parkinson’s disease dementia (PDD) and vascular parkinsonism with dementia (VPD). However, whether they can...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JKL International LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772858/ https://www.ncbi.nlm.nih.gov/pubmed/29392081 http://dx.doi.org/10.14336/AD.2017.0416 |
_version_ | 1783293473812643840 |
---|---|
author | Zou, Jing Chen, Zhigang Liang, Caiqian Fu, Yongmei Wei, Xiaobo Lu, Jianjun Pan, Mengqiu Guo, Yue Liao, Xinxue Xie, Huifang Wu, Duobin Li, Min Liang, Lihui Wang, Penghua Wang, Qing |
author_facet | Zou, Jing Chen, Zhigang Liang, Caiqian Fu, Yongmei Wei, Xiaobo Lu, Jianjun Pan, Mengqiu Guo, Yue Liao, Xinxue Xie, Huifang Wu, Duobin Li, Min Liang, Lihui Wang, Penghua Wang, Qing |
author_sort | Zou, Jing |
collection | PubMed |
description | Trefoil factor 3 (TFF3), cholinesterase activity (ChE activity) and homocysteine (Hcy) play critical roles in modulating recognition, learning and memory in neurodegenerative diseases, such as Parkinson’s disease dementia (PDD) and vascular parkinsonism with dementia (VPD). However, whether they can be used as reliable predictors to evaluate the severity and progression of PDD and VPD remains largely unknown. Methods: We performed a cross-sectional study that included 92 patients with PDD, 82 patients with VPD and 80 healthy controls. Serum levels of TFF3, ChE activity and Hcy were measured. Several scales were used to rate the severity of PDD and VPD. Receivers operating characteristic (ROC) curves were applied to map the diagnostic accuracy of PDD and VPD patients compared to healthy subjects. Results: Compared with healthy subjects, the serum levels of TFF3 and ChE activity were lower, while Hcy was higher in the PDD and VPD patients. These findings were especially prominent in male patients. The three biomarkers displayed differences between PDD and VPD sub-groups based on genders and UPDRS (III) scores’ distribution. Interestingly, these increased serum Hcy levels were significantly and inversely correlated with decreased TFF3/ChE activity levels. There were significant correlations between TFF3/ChE activity/Hcy levels and PDD/VPD severities, including motor dysfunction, declining cognition and mood/gastrointestinal symptoms. Additionally, ROC curves for the combination of TFF3, ChE activity and Hcy showed potential diagnostic value in discriminating PDD and VPD patients from healthy controls. Conclusions: Our findings suggest that serum TFF3, ChE activity and Hcy levels may underlie the pathophysiological mechanisms of PDD and VPD. As the race to find biomarkers or predictors for these diseases intensifies, a better understanding of the roles of TFF3, ChE activity and Hcy may yield insights into the pathogenesis of PDD and VPD. |
format | Online Article Text |
id | pubmed-5772858 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | JKL International LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-57728582018-02-02 Trefoil Factor 3, Cholinesterase and Homocysteine: Potential Predictors for Parkinson’s Disease Dementia and Vascular Parkinsonism Dementia in Advanced Stage Zou, Jing Chen, Zhigang Liang, Caiqian Fu, Yongmei Wei, Xiaobo Lu, Jianjun Pan, Mengqiu Guo, Yue Liao, Xinxue Xie, Huifang Wu, Duobin Li, Min Liang, Lihui Wang, Penghua Wang, Qing Aging Dis Orginal Article Trefoil factor 3 (TFF3), cholinesterase activity (ChE activity) and homocysteine (Hcy) play critical roles in modulating recognition, learning and memory in neurodegenerative diseases, such as Parkinson’s disease dementia (PDD) and vascular parkinsonism with dementia (VPD). However, whether they can be used as reliable predictors to evaluate the severity and progression of PDD and VPD remains largely unknown. Methods: We performed a cross-sectional study that included 92 patients with PDD, 82 patients with VPD and 80 healthy controls. Serum levels of TFF3, ChE activity and Hcy were measured. Several scales were used to rate the severity of PDD and VPD. Receivers operating characteristic (ROC) curves were applied to map the diagnostic accuracy of PDD and VPD patients compared to healthy subjects. Results: Compared with healthy subjects, the serum levels of TFF3 and ChE activity were lower, while Hcy was higher in the PDD and VPD patients. These findings were especially prominent in male patients. The three biomarkers displayed differences between PDD and VPD sub-groups based on genders and UPDRS (III) scores’ distribution. Interestingly, these increased serum Hcy levels were significantly and inversely correlated with decreased TFF3/ChE activity levels. There were significant correlations between TFF3/ChE activity/Hcy levels and PDD/VPD severities, including motor dysfunction, declining cognition and mood/gastrointestinal symptoms. Additionally, ROC curves for the combination of TFF3, ChE activity and Hcy showed potential diagnostic value in discriminating PDD and VPD patients from healthy controls. Conclusions: Our findings suggest that serum TFF3, ChE activity and Hcy levels may underlie the pathophysiological mechanisms of PDD and VPD. As the race to find biomarkers or predictors for these diseases intensifies, a better understanding of the roles of TFF3, ChE activity and Hcy may yield insights into the pathogenesis of PDD and VPD. JKL International LLC 2018-02-01 /pmc/articles/PMC5772858/ /pubmed/29392081 http://dx.doi.org/10.14336/AD.2017.0416 Text en Copyright: © 2017 Zhou et al. http://creativecommons.org/licenses/by/2.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed. |
spellingShingle | Orginal Article Zou, Jing Chen, Zhigang Liang, Caiqian Fu, Yongmei Wei, Xiaobo Lu, Jianjun Pan, Mengqiu Guo, Yue Liao, Xinxue Xie, Huifang Wu, Duobin Li, Min Liang, Lihui Wang, Penghua Wang, Qing Trefoil Factor 3, Cholinesterase and Homocysteine: Potential Predictors for Parkinson’s Disease Dementia and Vascular Parkinsonism Dementia in Advanced Stage |
title | Trefoil Factor 3, Cholinesterase and Homocysteine: Potential Predictors for Parkinson’s Disease Dementia and Vascular Parkinsonism Dementia in Advanced Stage |
title_full | Trefoil Factor 3, Cholinesterase and Homocysteine: Potential Predictors for Parkinson’s Disease Dementia and Vascular Parkinsonism Dementia in Advanced Stage |
title_fullStr | Trefoil Factor 3, Cholinesterase and Homocysteine: Potential Predictors for Parkinson’s Disease Dementia and Vascular Parkinsonism Dementia in Advanced Stage |
title_full_unstemmed | Trefoil Factor 3, Cholinesterase and Homocysteine: Potential Predictors for Parkinson’s Disease Dementia and Vascular Parkinsonism Dementia in Advanced Stage |
title_short | Trefoil Factor 3, Cholinesterase and Homocysteine: Potential Predictors for Parkinson’s Disease Dementia and Vascular Parkinsonism Dementia in Advanced Stage |
title_sort | trefoil factor 3, cholinesterase and homocysteine: potential predictors for parkinson’s disease dementia and vascular parkinsonism dementia in advanced stage |
topic | Orginal Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772858/ https://www.ncbi.nlm.nih.gov/pubmed/29392081 http://dx.doi.org/10.14336/AD.2017.0416 |
work_keys_str_mv | AT zoujing trefoilfactor3cholinesteraseandhomocysteinepotentialpredictorsforparkinsonsdiseasedementiaandvascularparkinsonismdementiainadvancedstage AT chenzhigang trefoilfactor3cholinesteraseandhomocysteinepotentialpredictorsforparkinsonsdiseasedementiaandvascularparkinsonismdementiainadvancedstage AT liangcaiqian trefoilfactor3cholinesteraseandhomocysteinepotentialpredictorsforparkinsonsdiseasedementiaandvascularparkinsonismdementiainadvancedstage AT fuyongmei trefoilfactor3cholinesteraseandhomocysteinepotentialpredictorsforparkinsonsdiseasedementiaandvascularparkinsonismdementiainadvancedstage AT weixiaobo trefoilfactor3cholinesteraseandhomocysteinepotentialpredictorsforparkinsonsdiseasedementiaandvascularparkinsonismdementiainadvancedstage AT lujianjun trefoilfactor3cholinesteraseandhomocysteinepotentialpredictorsforparkinsonsdiseasedementiaandvascularparkinsonismdementiainadvancedstage AT panmengqiu trefoilfactor3cholinesteraseandhomocysteinepotentialpredictorsforparkinsonsdiseasedementiaandvascularparkinsonismdementiainadvancedstage AT guoyue trefoilfactor3cholinesteraseandhomocysteinepotentialpredictorsforparkinsonsdiseasedementiaandvascularparkinsonismdementiainadvancedstage AT liaoxinxue trefoilfactor3cholinesteraseandhomocysteinepotentialpredictorsforparkinsonsdiseasedementiaandvascularparkinsonismdementiainadvancedstage AT xiehuifang trefoilfactor3cholinesteraseandhomocysteinepotentialpredictorsforparkinsonsdiseasedementiaandvascularparkinsonismdementiainadvancedstage AT wuduobin trefoilfactor3cholinesteraseandhomocysteinepotentialpredictorsforparkinsonsdiseasedementiaandvascularparkinsonismdementiainadvancedstage AT limin trefoilfactor3cholinesteraseandhomocysteinepotentialpredictorsforparkinsonsdiseasedementiaandvascularparkinsonismdementiainadvancedstage AT lianglihui trefoilfactor3cholinesteraseandhomocysteinepotentialpredictorsforparkinsonsdiseasedementiaandvascularparkinsonismdementiainadvancedstage AT wangpenghua trefoilfactor3cholinesteraseandhomocysteinepotentialpredictorsforparkinsonsdiseasedementiaandvascularparkinsonismdementiainadvancedstage AT wangqing trefoilfactor3cholinesteraseandhomocysteinepotentialpredictorsforparkinsonsdiseasedementiaandvascularparkinsonismdementiainadvancedstage |